Gene therapy progress and prospects: targeted gene repair.
about
Oligonucleotide-directed mutagenesis for precision gene editingGenetic spell-checking: gene editing using single-stranded DNA oligonucleotidesTargeted nucleotide exchange in bovine myostatin gene.Reduction of gene repair by selenomethionine with the use of single-stranded oligonucleotides.Manipulation of cell cycle progression can counteract the apparent loss of correction frequency following oligonucleotide-directed gene repair.Simultaneous targeted exchange of two nucleotides by single-stranded oligonucleotides clusters within a region of about fourteen nucleotides.Gene therapy for the inner ear: challenges and promises.Adeno-associated virus gene repair corrects a mouse model of hereditary tyrosinemia in vivo.The involvement of replication in single stranded oligonucleotide-mediated gene repair.Targeted In Situ Gene Correction of Dysfunctional APOE Alleles to Produce Atheroprotective Plasma ApoE3 Protein.AAV-mediated gene targeting is significantly enhanced by transient inhibition of nonhomologous end joining or the proteasome in vivoGene therapeutics for periodontal regenerative medicine.Progress and prospects: targeted gene alteration (TGA).Analyses of point mutation repair and allelic heterogeneity generated by CRISPR/Cas9 and single-stranded DNA oligonucleotides.Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application.An update on targeted gene repair in mammalian cells: methods and mechanismsPolypropylenimine generation four: a suitable vector for targeted gene alteration in vitro.Oligonucleotide-mediated gene editing is underestimated in cells expressing mutated green fluorescent protein and is positively associated with target protein expression.DNA breakage associated with targeted gene alteration directed by DNA oligonucleotides.Multiple roles for MSH2 in the repair of a deletion mutation directed by modified single-stranded oligonucleotides.Third strand-mediated psoralen-induced correction of the sickle cell mutation on a plasmid transfected into COS-7 cells.Recovery of cell cycle delay following targeted gene repair by oligonucleotides.Oligonucleotide delivery by nucleofection does not rescue the reduced proliferation phenotype of gene-edited cellsGene therapy in periodontics.Strand bias influences the mechanism of gene editing directed by single-stranded DNA oligonucleotides.DNA damage response pathway and replication fork stress during oligonucleotide directed gene editing.A Standard Methodology to Examine On-site Mutagenicity As a Function of Point Mutation Repair Catalyzed by CRISPR/Cas9 and SsODN in Human CellsDelivery and mechanistic considerations for the production of knock-in mice by single-stranded oligonucleotide gene targeting.Modification of the pig CFTR gene mediated by small fragment homologous replacement.Genetic modification through oligonucleotide-mediated mutagenesis. A GMO regulatory challenge?Asymmetrically functionalized β-cyclodextrin-based star copolymers for integrated gene delivery and magnetic resonance imaging contrast enhancement
P2860
Q26778792-56880F72-64D3-4A5A-ACA5-FEE946F0666DQ26781566-22E58611-CD0C-4A09-9E8A-6C838880CA33Q30374470-F1772CDF-79F7-4A4B-B4FB-D87F7F2622DEQ33270548-360A9BA2-23F9-4DC4-8CB3-5E5A4A82EDA0Q33272502-FA239925-FF9E-45A2-BAF7-0E93430F1CBDQ33316832-918C5BA4-A9E1-4078-895C-044433D65A85Q35095260-A027A552-BB59-4D8D-8AB9-969C8555C9F3Q35105022-CBAC02E7-460D-4C9C-B516-2BC959D2BCD4Q35215217-5C1BDC98-8A73-40D3-8196-A8B9D2E8BCA9Q35974993-CC9C9A02-70E7-4A74-BB40-5C9B605CB01AQ36084471-5AF66F29-5E6F-4457-9D80-3B353620A52CQ36418370-1C0891F6-A860-453A-8EB3-D441259F23BFQ36986953-C6EDF025-9A71-4446-A714-F531C4BD749AQ37243530-CAA869ED-0AD0-4C7E-9A79-BEC5992B4249Q37821231-63D2BBB9-B3B0-4A69-B76E-20541B482D7FQ37834094-5A4E08E2-CADE-4951-B310-EE5871AA1A1FQ39350059-0E229B5E-9B37-4AE1-895C-F7BCD193B695Q39415426-05C295AD-B2D2-454C-BBCB-11AB3AAE80DBQ39848054-BAF33B49-8A31-435B-B704-DDB6E886A040Q40206773-88331B6A-65FB-4BAF-9132-848C45B8D221Q40237708-FDB16108-BBEB-4E7F-8EEF-1A11F2AC91B7Q40284701-080F4561-1A78-4B2B-A496-558F02544236Q41812045-07FAF1E2-482A-45C1-BC90-22BC4F624F43Q41830129-16DA5582-C9A0-4959-BC62-57C2B92ACC06Q41898361-DEEF8B10-6EF5-4ACC-9E9C-66B421E1FF28Q42089537-BE87DC7A-577A-4E7E-9D95-B8FE46A37D0FQ42278013-2AE111DE-7433-4B52-9E63-37E36BBEB7C6Q45863025-F0068753-F253-4850-B5D0-85FFCC005356Q46260202-2B289C33-1398-4065-AF19-838A51E1441CQ53185754-B81A536E-CE6F-4752-86B3-114963D0C6DDQ58068471-9FAD659C-C237-47AB-BB43-7697BD472084
P2860
Gene therapy progress and prospects: targeted gene repair.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Gene therapy progress and prospects: targeted gene repair.
@ast
Gene therapy progress and prospects: targeted gene repair.
@en
type
label
Gene therapy progress and prospects: targeted gene repair.
@ast
Gene therapy progress and prospects: targeted gene repair.
@en
prefLabel
Gene therapy progress and prospects: targeted gene repair.
@ast
Gene therapy progress and prospects: targeted gene repair.
@en
P2093
P2860
P356
P1433
P1476
Gene therapy progress and prospects: targeted gene repair.
@en
P2093
Brachman E
Parekh-Olmedo H
P2860
P2888
P304
P356
10.1038/SJ.GT.3302511
P577
2005-04-01T00:00:00Z